TY  - GEN
AU  - Grover,S A
AU  - Coupal,L
AU  - Paquet,S
AU  - Zowall,H
TI  - Cost-effectiveness of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the secondary prevention of cardiovascular disease: forecasting the incremental benefits of preventing coronary and cerebrovascular events
SN  - 0003-9926
PY  - 1999///0407
KW  - Adult
KW  - Aged
KW  - Canada
KW  - Cardiovascular Diseases
KW  - economics
KW  - Cerebrovascular Disorders
KW  - Cost-Benefit Analysis
KW  - Drug Costs
KW  - Female
KW  - Humans
KW  - Hydroxymethylglutaryl-CoA Reductase Inhibitors
KW  - Hypolipidemic Agents
KW  - Life Expectancy
KW  - Male
KW  - Middle Aged
KW  - Recurrence
KW  - Risk
KW  - Scandinavian and Nordic Countries
KW  - Sensitivity and Specificity
KW  - Simvastatin
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1001/archinte.159.6.593
ER  -